Schillinger and Minar Ross R. 1999. Atherosclerosis – an inflammatory disease. N Engl J Med, 340:115–26. Schillinger M, Exner M, Mlekusch W, et al. 2002a. Vascular inflammation and percutaneous transluminal of the femoropopliteal artery: association with restenosis. Radiology, 225:21–6. Schillinger M, Exner M, Mlekusch W, et al. 2002b. Fibrinogen and restenosis after endovascular treatment of the iliac arteries: a marker of inflammation or coagulation? Thromb Haemost, 87:959–65. Schillinger M, Exner M, Mlekusch W, et al. 2002c. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther, 9:59–66. Schillinger M, Exner M, Mlekusch W, et al. 2002d. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology, 224:529–35. Schillinger M, Exner M, Mlekusch W, et al. 2002e. Heme oxygenase-1 genotype is a vascular anti-inflammatory factor following balloon angioplasty. J Endovasc Ther, 9:385–94. Schillinger M, Exner M, Mlekusch W, et al. 2003a. Endovascular revascularisation below the knee: 6 months results and predictive value of C-reactive protein level. Radiology, 227:419–25. Schillinger M, Exner M, Mlekusch W, et al. 2003b. Acute phase response after stent implantation in the carotid artery: association with 6 months instent restenosis. Radiology, 227:516–21. Schillinger M, Exner M, Minar E, et al. 2004. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol, 43:950–7. Schillinger M, Haumer M, Schlerka G, et al. 2001. Restenosis after percutaneous transluminal angioplasty in patients with peripheral artery disease: the role of inflammation. J Endovasc Ther, 8:477–83. Serrano CV, Ramires JA, Venturinelli M, et al. 1997. Coronary angioplasty results in leucocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol, 29:1276–83. Sousa JE, Costa MA, Abizaid AC, et al. 2001. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one year angiographic and intravascular ultrasound follow-up. Circulation, 104:2007–11. Suzuki T, Kopia G, Hayashi S, et al. 2001. Stent-based delivery of sirolimus reduces neointimal formation in a procine coronary model. Circulation, 104:1188–93. Tanguay JF, Geoffroy P, Sirois MG, et al. 2004. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost, 91:1186–93. Tenhunen R, Marver HS, Schmid R. 1969. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem, 244:6388–94. Tetteroo E, van der Graaf Y, Bosch JL, et al. 1998. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study group. Lancet, 351:1153–9. Torzewski J, Torzewski M, Bowyer DE, et al. 1998. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 18:1386–92. Tsakiris DA, Tschopl M, Jager K, et al. 1999. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis, 142:193–200. Tschöpl M, Tsakiris DA, Marbet GA, et al. 1997. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol, 17: 3208–14. Tulis DA, Durante W, Peyton KJ, et al. 2001. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis, 155:113–22. Verma S, Wang CH, Li SH, et al. 2002. A self-fulfilling prophecy: C- reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 106:913–19. Versaci F, Gaspardone A, Tomai F, et al. 2002. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol, 40:1935–42. Virmani R, Farb A. 1999. Pathology of in-stent restenosis. Curr Opin Lipidol, 10:499–506. Wilcox JN, Okamoto EI, Nakahara KI, et al. 2001. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblasts precursors? Ann N Y Acad Sci, 947:68–90. Yamada N,Yamaya M, Okinaga S, et al. 2000. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 66:187–95. Yokoyama T, Miyauchi K, Kurata T. 2004. Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting. Atherosclerosis, 174:253–9. Young B, Gleeson M, Cripps AW. 1991. C-reactive protein: a critical review. Pathology, 23:118–24. Yutani C, Ishibashi-Ueda H, Suzuki T, et al. 1999. Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent stenosis. Cardiology, 92:171–7. 78 Vascular Health and Risk Management 2005:1(1)